|[April 03, 2014]
Research and Markets: Leukemia Partnering 2009-2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/pdtlck/leukemia)
has announced the addition of the "Leukemia
Partnering 2009-2014" report to their offering.
The Leukemia Partnering 2009-2014 provides understanding and access to
the leukemia partnering deals and agreements entered into by the worlds
leading healthcare companies.
The report provides an analysis of leukemia partnering deals. Th
majority of deals are discovery or development stage whereby the
licensee obtains a right or an option right to license the licensors
leukemia technology. These deals tend to be multicomponent, starting
with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated
deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered - contract documents provide this insight where press releases
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in leukemia partnering
Chapter 3 - Leading leukemia deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/pdtlck/leukemia
[ Back To TMCnet.com's Homepage ]